How many Alnylam Pharmaceuticals shares are in issue?
Alnylam Pharmaceuticals has 128,980,917 shares in issue.
What is the market cap of Alnylam Pharmaceuticals?
The market capitalisation of Alnylam Pharmaceuticals is USD 32.63 B.
What is the 1 year trading range for Alnylam Pharmaceuticals share price?
Alnylam Pharmaceuticals has traded in the range of US$ 141.975 to US$ 304.39 during the past year.
What is the PE ratio of Alnylam Pharmaceuticals?
The price to earnings ratio of Alnylam Pharmaceuticals is -73.93.
What is the cash to sales ratio of Alnylam Pharmaceuticals?
The cash to sales ratio of Alnylam Pharmaceuticals is 17.80.
What is the reporting currency for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals reports financial results in USD.
What is the latest annual turnover for Alnylam Pharmaceuticals?
The latest annual turnover of Alnylam Pharmaceuticals is USD 1.83B.
What is the latest annual profit for Alnylam Pharmaceuticals?
The latest annual profit of Alnylam Pharmaceuticals is USD -440.24M.
What is the registered address of Alnylam Pharmaceuticals?
The registered address for Alnylam Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801.
What is the Alnylam Pharmaceuticals website address?
The website address for Alnylam Pharmaceuticals is www.alnylam.com.
Which industry sector does Alnylam Pharmaceuticals operate in?
Alnylam Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
